Rapid discontinuation of prednisone in higher-risk kidney transplant recipients

被引：30

作者：

Khwaja, K ^{[1
]}

Asolati, M ^{[1
]}

Harmon, JV ^{[1
]}

Melancon, JK ^{[1
]}

Dunn, TB ^{[1
]}

Gillingham, KJ ^{[1
]}

Kandaswamy, R ^{[1
]}

Humar, A ^{[1
]}

Gruessner, RWG ^{[1
]}

Payne, WD ^{[1
]}

Najarian, JS ^{[1
]}

Dunn, DL ^{[1
]}

Sutherland, DER ^{[1
]}

Matas, AJ ^{[1
]}

机构：

[1] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA

来源：

TRANSPLANTATION | 2004年 / 78卷 / 09期

关键词：

immunosuppression;

D O I：

10.1097/01.TP.0000136964.59494.FF

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Prednisone-minimization protocols have been successful in low-risk recipients. We report on the use of a protocol incorporating rapid discontinuation of prednisone in a cohort of kidney transplant recipients (n = 79) at increased immunologic risk. Our data suggests that such recipients should not be excluded from prednisone-minimization protocols.

引用

收藏

页码：1397 / 1399

页数：3

相关论文

共 14 条

[1]

Ahsan N, 1999, TRANSPLANTATION, V68, P1865

[2] Steroid-free immunosuppression in renal transplantation - A long-term follow-up of 100 consecutive patients [J].

Birkeland, SA .

TRANSPLANTATION, 2001, 71 (08) :1089-1090

[3] Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: A pilot study [J].

Boots, JMM ;

Christiaans, MHL ;

van Duijnhoven, EM ;

van Suylen, RJ ;

van Hooff, JP .

TRANSPLANTATION, 2002, 74 (12) :1703-1709

[4] Daclizumab (humanized anti-IL2rα mab) prophylaxis for prevention of acute rejection in renal transplant recipients with delayed graft function [J].

Bumgardner, GL ;

Ramos, E ;

Lin, A ;

Vincenti, F .

TRANSPLANTATION, 2001, 72 (04) :642-647

[5] Campath 1H allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients [J].

Calne, R ;

Moffatt, SD ;

Friend, PJ ;

Jamieson, NV ;

Bradley, JA ;

Hale, G ;

Firth, J ;

Bradley, J ;

Smith, KGC ;

Waldmann, M .

TRANSPLANTATION, 1999, 68 (10) :1613-1616

[6]

CECKA MJ, 2002, CLIN TRANSPLANT, V16, P1

[7] A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. [J].

Cole, E ;

Landsberg, D ;

Russell, D ;

Zaltzman, J ;

Kiberd, B ;

Caravaggio, C ;

Vasquez, AR ;

Halloran, P .

TRANSPLANTATION, 2001, 72 (05) :845-850

[8] Safety and efficacy of TOR inhibitors and other immunosuppressive regimens in African-American renal transplant recipients [J].

Hricik, DE .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) :S11-S15

[9] Immediate and long-term results of ATG induction therapy for delayed graft function compared to conventional therapy for immediate graft function [J].

Lange, H ;

Müller, TF ;

Ebel, H ;

Kuhlmann, U ;

Grebe, SO ;

Heymanns, J ;

Feiber, H ;

Riedmiller, H .

TRANSPLANT INTERNATIONAL, 1999, 12 (01) :2-9

[10]

LEVENTHAL JR, 2003, AM J TRANSPLANT, V3, P439